Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Yonago, Japan.
Eur J Endocrinol. 2020 Mar;182(3):363-374. doi: 10.1530/EJE-19-0859.
Pregnancy-associated plasma protein-A2 (PAPP-A2) is a metalloproteinase that cleaves IGFBP-3 and IGFBP-5. Human mutations in PAPPA2 result in short stature with a low percentage of free IGF-I. Little is known about PAPP-A2 levels and the regulation of free IGF-I throughout childhood. We examined PAPP-A2 and intact IGFBP-3 levels in childhood and explored associations between PAPP-A2, free and total IGF-I, and total and intact IGFBP-3 and their relationship to the percentage of free to total IGF-I and anthropometric factors.
Cross-sectional study at a single center.
PAPP-A2, free IGF-I, and intact IGFBP-3 levels were measured in childhood (3-18 years old) and an evaluation of the relationship between these proteins and anthropometric factors.
In 838 children, PAPP-A2 consistently decreased throughout childhood. In contrast, free IGF-I increased. A pubertal peak in free IGF-I was present in females but was less evident in males. Intact and total IGFBP-3 increased throughout childhood; however, intact IGFBP-3 had a more marked rise than total IGFBP-3. Percent free IGF-I decreased with no distinct pubertal peak. PAPP-A2 levels positively correlated with the percent free IGF-I (Male, Female; r = 0.18, 0.38; P < 0.001) and negatively with intact IGFBP-3 (Male, Female; r = -0.58, -0.65; P < 0.0001).
This is the first study to describe serum PAPP-A2 and intact IGFBP-3 in children between 3 and 18 years of age. Our correlative findings suggest that PAPP-A2 is an important regulator of the percent free IGF-I which can be a marker of perturbations in the GH/IGF-I axis.
妊娠相关血浆蛋白 A2(PAPP-A2)是一种金属蛋白酶,可切割 IGFBP-3 和 IGFBP-5。人类 PAPPA2 基因突变导致 IGF-I 游离百分比低的身材矮小。关于儿童期 PAPP-A2 水平和游离 IGF-I 的调节知之甚少。我们检测了儿童期的 PAPP-A2 和完整的 IGFBP-3 水平,并探讨了 PAPP-A2、游离和总 IGF-I 以及总和完整 IGFBP-3 之间的关系及其与游离 IGF-I 与总 IGF-I 百分比和人体测量因素的关系。
单中心横断面研究。
在儿童期(3-18 岁)测量 PAPP-A2、游离 IGF-I 和完整 IGFBP-3 水平,并评估这些蛋白质与人体测量因素之间的关系。
在 838 名儿童中,PAPP-A2 在整个儿童期持续下降。相比之下,游离 IGF-I 增加。女性中存在游离 IGF-I 的青春期高峰,但在男性中不太明显。完整和总 IGFBP-3 在整个儿童期均增加;然而,完整 IGFBP-3 的上升幅度大于总 IGFBP-3。游离 IGF-I 的百分比下降,没有明显的青春期高峰。PAPP-A2 水平与游离 IGF-I 的百分比呈正相关(男性、女性;r = 0.18,0.38;P < 0.001),与完整 IGFBP-3 呈负相关(男性、女性;r = -0.58,-0.65;P < 0.0001)。
这是第一项描述 3 至 18 岁儿童血清 PAPP-A2 和完整 IGFBP-3 的研究。我们的相关发现表明,PAPP-A2 是游离 IGF-I 百分比的重要调节剂,它可以作为 GH/IGF-I 轴扰动的标志物。